Colorectal cancer medicines
Metastatic colorectal cancer treatment depends on RAS/BRAF, MSI status, and prior therapy. We highlight biologics we stock; chemotherapy backbones are clinic-administered and not listed as a complete protocol here.
Bevacizumab (Avastin) is commonly combined with chemotherapy in eligible metastatic colorectal cancer.
Immunotherapy such as pembrolizumab may be used in MSI-high / dMMR colorectal cancer when the oncologist selects it.
Anti-EGFR antibodies are not listed here unless we stock them — do not assume cetuximab from this page.
Medicines we stock in this area
Each card opens the existing /shop product URL. Protocols are chosen only by the oncologist.
VEGF
Avastin Bevacizumab 400mg
Open productVEGF
Avastin Bevacizumab 100mg
Open productMSI-H / PD-1
Keytruda Pembrolizumab 100mg
Open productInformation and pharmacy-access support only — not medical advice, diagnosis, or a treatment plan. Always follow your oncologist. Prescription required for oncology medicines.